These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8839655)

  • 21. Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
    Lampl C; Voelker M; Diener HC
    J Neurol; 2007 Jun; 254(6):705-12. PubMed ID: 17406776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Migraine and cluster headache--their management with sumatriptan: a critical review of the current clinical experience.
    Wilkinson M; Pfaffenrath V; Schoenen J; Diener HC; Steiner TJ
    Cephalalgia; 1995 Oct; 15(5):337-57. PubMed ID: 8536293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Daily sumatriptan for detoxification from rebound.
    Drucker P; Tepper S
    Headache; 1998 Oct; 38(9):687-90. PubMed ID: 15613182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sumatriptan in the treatment of cluster headache and migraine attacks].
    Kolosova OA; Osipova VV; Khomak EB; Bobeĭko LA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(5):12-5. PubMed ID: 7900441
    [No Abstract]   [Full Text] [Related]  

  • 25. How does sumatriptan perform in clinical practice?
    Dahlöf CG
    Cephalalgia; 1995 Oct; 15 Suppl 15():21-8. PubMed ID: 8749242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice.
    Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS
    Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sumatriptan treatment of migraine in general practice. A randomized, double-blind, placebo-controlled cross-over study].
    Russell MB; Holm-Thomsen OE; Nielsen MR; Cleal A; Pilgrim AJ; Olesen J
    Ugeskr Laeger; 1995 Apr; 157(16):2320-3. PubMed ID: 7652970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks].
    Göbel H; Stolze H; Heinze A; Dworschak M; Heuss D; Christiani K; Lindner V
    Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in perceived and presented adverse drug reactions in general practice.
    Ottervanger JP; Valkenburg HA; Grobbee DE; Stricker BH
    J Clin Epidemiol; 1998 Sep; 51(9):795-9. PubMed ID: 9731928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
    Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
    Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study.
    Göbel H; Lindner V; Heinze A; Ribbat M; Deuschl G
    Neurology; 1998 Sep; 51(3):908-11. PubMed ID: 9748059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug-clinics. The drug of the month. Imitrex nasal spray (sumatriptan)].
    Scheen AJ
    Rev Med Liege; 1997 Sep; 52(9):610-2. PubMed ID: 9441347
    [No Abstract]   [Full Text] [Related]  

  • 33. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group.
    J Int Med Res; 1994; 22(4):225-35. PubMed ID: 7958382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sumatriptan in the treatment of migraine in general practice].
    Midelfart E; Winnem M
    Tidsskr Nor Laegeforen; 1994 Nov; 114(29):3430-2. PubMed ID: 7998046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Headache medication-use among primary care headache patients in a health maintenance organization.
    Von Korff M; Black LK; Saunders K; Galer BS
    Cephalalgia; 1999 Jul; 19(6):575-80; discussion 541-2. PubMed ID: 10448544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zelrix: a novel transdermal formulation of sumatriptan.
    Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
    Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan.
    Dowson AJ; Massiou H; Aurora SK
    J Headache Pain; 2005 Apr; 6(2):81-7. PubMed ID: 16362647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cluster headache attacks with less than 6 mg subcutaneous sumatriptan.
    Gregor N; Schlesiger C; Akova-Oztürk E; Kraemer C; Husstedt IW; Evers S
    Headache; 2005 Sep; 45(8):1069-72. PubMed ID: 16109122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults.
    Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S
    Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aspirin, triptan tablet, nasal spray, injection. Even the most severe migraine capitulates].
    Wiedemann B
    MMW Fortschr Med; 2001 Apr; 143(16):6. PubMed ID: 11368000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.